Noveome is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of inflammatory and neurological disorders. Noveome was founded in 2000. Noveome's headquarters is located in Pittsburgh, P... Noveome's CEO, Christopher J. P. Velis, currently has an approval
rating of 90%. Noveome's primary competitors are Complexa, Therasource & ContraFect.
There have been no acquisitions found related to Noveome
Recent investment data cannot be found related to Noveome